Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Metformin for the Treatment of Diabetes in Pregnancy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2006 by Soroka University Medical Center.
Recruitment status was:  Not yet recruiting
Ben-Gurion University of the Negev
Information provided by:
Soroka University Medical Center Identifier:
First received: December 20, 2006
Last updated: NA
Last verified: December 2006
History: No changes posted
The purpose of this study is to determine whether metformin is effective and safe in the treatment of diabetes in pregnancy.

Condition Intervention Phase
Gestational Diabetes
Diabetes Mellitus Type 2
Drug: metformin
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Metformin for the Treatment of Diabetes in Pregnancy

Resource links provided by NLM:

Further study details as provided by Soroka University Medical Center:

Primary Outcome Measures:
  • glycemic control
  • pregnancy complications

Estimated Enrollment: 200
Study Start Date: January 2007

Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • pregnant women
  • GDM A2
  • diabetes mellitus type 2
  • singleton pregnancy

Exclusion Criteria:

  • diabetic nephropathy or proliferative retinopathy
  • cannot swallow tablets
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00414245

Contact: Boaz Sheizaf, MD 972-54-2401191

Division of Obstetrics and Gynecology, Soroka University Medical Center Not yet recruiting
Beer-Sheva, Israel
Contact: Boaz Sheizaf, MD    972-54-2401191   
Principal Investigator: Boaz Sheizaf, MD         
Sponsors and Collaborators
Soroka University Medical Center
Ben-Gurion University of the Negev
Principal Investigator: Boaz Sheizaf, MD division of obstetrics and gynecology, soroka university medical center
  More Information Identifier: NCT00414245     History of Changes
Other Study ID Numbers: sor434306ctil
Study First Received: December 20, 2006
Last Updated: December 20, 2006

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes, Gestational
Diabetes Mellitus, Type 2
Pregnancy in Diabetics
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Pregnancy Complications
Hypoglycemic Agents
Physiological Effects of Drugs processed this record on May 25, 2017